MARATTO
UniversitiesMohamed H. A. Gadelmawla
Active, last published 2026

In chemotherapy-induced organ toxicity mitigation

Mohamed H. A.
Gadelmawla

ScholarScholar

Research focused on Chemotherapy-induced organ toxicity mitigation and adjacent fields.

Sinai University
Claim Your Profile

12

H-index

279

Citations

Mohamed has not officially claimed their profile. If you are Mohamed, claim it free.

Claim Your Profile
Pioneer

Pioneer

LOCKED

Pathfinder

Pathfinder

LOCKED

Scholar

Scholar

EARNED

Innovator

Innovator

LOCKED

Inventor

Inventor

LOCKED

Catalyst

Catalyst

LOCKED

Expert

Expert

UPGRADE

01 · About the work

What I study

ohamed H. A. Gadelmawla is a researcher working on Chemotherapy-induced organ toxicity mitigation. A fuller summary will appear once they update their profile.

02 · Reach

Publication output and reach

Mohamed's work has been cited 279 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.

03 · Research focus

Topics

Chemotherapy-induced organ toxicity mitigation×8Drug-Induced Hepatotoxicity and Protection×5Selenium in Biological Systems×4Chemotherapy-induced cardiotoxicity and mitigation×4Acute Kidney Injury Research×3
04 · Where I am

Affiliations

Affiliation on published researchSinai UniversityDrawn from the institution listed on this researcher’s published work.

Research themes (UN SDGs)

05 · Selected work

Recent publications

21 works

Expert Academic Profiles go further

Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.

Explore Expert

Are you Mohamed?

Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.

African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.

Claim Your Profile

Free to claim · takes a minute to verify it’s you